|
|
|
|
Evolution of Integrase in Virus at Protocol-Defined Virologic Failure From the VIKING-3 Study
|
|
|
Reported by Jules Levin
International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies; June 4-8, 2013; Toronto, ON, Canada
CL Vavro,1 J Huang,2 M Ait-Khaled,3 JM Yeo3
GlaxoSmithKline, 1Research Triangle Park, NC, USA; 2Toronto, ON, Canada; 3Stockley Park, London, UK
|
|
|
|
|
|
|